Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
(NASDAQ: ACHV) Delayed: 5.10 +0.25 (5.15%)
Previous Close $4.85    52 Week High $ 
Open $4.94    52 Week Low $ 
Day High $5.43    P/E N/A 
Day Low $4.94    EPS $ 
Volume 2,898,141